Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition - Szymansky, A; Menon, R; Witthauer, MJ; Winkler, A; Pogodzinski, MJ; Overath, MD; Toedling, J; Hertwig, F; Schönbeck, K; Heukamp, L; Heukmann, J; Hundsdoerfer, P; Eggert, A; Fischer, M; Eckert, C; Schulte, JH (Klinische Pädiatrie, 2018)